Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice

Indian Journal of Experimental Biology

Volumn 46, Issue 3, 2008, Pages 180-184

  Nayak, Veena ^a   Patil, P A ^a  

^a JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

Author keywords

Anxiety; Depression; Fosinopril; Lisinopril; Losartan; Ramipril

Indexed keywords

ANIMALIA; MUS; RATTUS;

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; FOSINOPRIL; LISINOPRIL; LOSARTAN; RAMIPRIL;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; LONG TERM DEPRESSION; MALE; MOTOR ACTIVITY; MOUSE; RAT; WISTAR RAT;

AMITRIPTYLINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; FOSINOPRIL; LISINOPRIL; LONG-TERM SYNAPTIC DEPRESSION; LOSARTAN; MALE; MICE; MOTOR ACTIVITY; RAMIPRIL; RATS; RATS, WISTAR;

EID: 45149132303     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. John M J, Drug Therapy: The Medical Management of Depression (review), N Eng J Med, 353 (2005) 1819.
2. Shrivastava S & Kochar M S, The dual risks of depression and hypertension, Postgraduate Med, 111 (2002) 1.
3. Giardina W J & Ebert D M, Positive effects of captopril in the behavioral despair swim test, Biol Psychiatry, 25 (1989) 697.
4. Martin P, Massol J, Scalbert E & Puech A J, Involvement of angiotensin converting enzyme inhibition in reversal of helpless behavior evoked by perindopril in rats, Eur J Pharmacol, 187 (1990) 165.
5. Gard P R, The role of angiotensin II in cognition and behaviour, Eur J Pharmacol 438 (2002) 1.
6. Vijayapandi Pandi & Nagappa A N, Biphasic effects of Losartan Potassium on Immobility in Mice, Pharmaceutical Soc Japan, 125 (2005) 653.
7. Germain L & Chouinard G, Treatment of recurrent Unipolar Major Depression with captopril (case report), Biol Psychiatry, 23 (1988) 637.
8. Braszko J J, Karwowska P W, Halicka D & Gard P R, Captopril and enalapril improve cognition and depressed mood in hypertensive patients, J Basic Clin Physiol Pharmacol, 14 (2003) 323.
9. Packaerts J, Raaijmakers W & Blokland A, Effects of myocardial infarction and captopril therapy on anxiety related behaviors in the rat, Physiol Behav, 60 (1996) 43.
10. Costal B, Domeney A M, Gerrard P A, Horovitz Z P, Kelly M E, Naylor J R & Tomkins D M, Effects of Captopril and SQ29852 on Anxiety related behaviors in Rodent and Marmoset, Pharmacol Biochem Behav, 36 (1990) 13.
11. Srinivasan J, Suresh B & Ramanathan M, Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats, J Physiol Behav, 78 (2003) 585.
12. Braszko J J, Kulakowska A & Winnicka M M, Effects of Angiotensin II and its receptor antagonists on motor activity and anxiety in rats, J Physiol Pharmacol, 54 (2003) 271.
13. Gunduz H, Georges J L & Fleishman S, Quinapril and Depression (letter), Am J Psychiatry, 156 (1999) 114.
14. th ed. ( McGraw Hill, New York) 2001, 789.
15. Piepho & Robert W, Overview of the angiotensin converting enzyme inhibitors, Am J Health Syst Pharm, 57 (2000) Supp1 S3.
16. rd ed. ( Hilton and company, Kolkota) 2005
17. Porsolt R D, Pichon M L & Jalfre M, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266 (1977) 730.
18. Steru L, Chermat R, Thierry B & Siman P, The tail suspension test: A new method for screening antidepressants in mice, Psychopharmacology, 85 (1985) 367.
19. Pellow S, Chopin P, Fil S E & Briely B, Validation of openclosed arm entries in elevated plus maze as a measure of anxiety in the rat, J Neurosci Methods, 14 (1985) 149.
20. Costall B, Domeney A M, Gerrad P A, Kelly M E & Naylor R, Zacopride: anxiolytic profile in rodents and primate models of anxiety, J Pharm Phamacol, 40 (1988) 302.
21. Broom D C, Jut Kiewicz E M, Rice K C, Traynor J R & Woods J H, Behaviour effects of δ opioid receptor agonists: potential antidepressants, Jpn J Pharmacol, 90 (2002) 1.
22. th ed. (Vol 1) (Lippincott Williams and Wilkins, Philadelphia) 2005, 534.
23. nd ed. (Foundation books, Cambridge University Press, New Delhi) 2000, 297.
24. Boyle M P, Brewer J A, Funatsu M, Wozniak D F, Tsien J Z. Izumi Y & Muglia L J, Acquired deficit of forebrain glucocorticoid receptor produces depression like changes in adrenal axis regulation and behavior, Neuroscience, 102 (2005) 473.
25. Wilson W, Voigt P, Bader M, Marsden C A & Fink H, Behaviour of the transgenic (mREN2) 27rat, Brain Res, 729 (1996) 1.
26. Okuyama S, Sakagawa T & Inagami T, Role of the Angiotensin II Type-2 Receptor in the mouse Central Nervous System (Review), Jpn J Pharmacol, 81 (1999) 259.
27. Okuyama S, Sakagawa T, Chaki S, Imagawa Y, Ichiki T & Inagami T, Anxiety like behavior in mice lacking the angiotensin II type 2 receptor, Brain Res, 821 (1999) 150.
28. De-Pei Li & Hui-Lin pan, Angiotensin II attenuates synaptic GABA release and excites paraventricular rostral ventrolateral medulla output neurons, J Pharmacol Exp Ther, 313 (2005) 1035.
29. Hadjiivanova C H & Georagierv V, Invitro effect of angiotensin II on GABA release in rat hippocampus, Neuropeptides, 32 (1998) 431.
30. Croog S H, Levine S, Testa M A, Brown B, Bulpitt C J & Jenkins C D, The effects of antihypertensive therapy on quality of life, N Eng J Med, 314 (1986) 1657.